Clinical trial
Effect of Alprazolam on Heart Rate and Acute Inflammatory Marker in Acute Coronary Syndrome Patients
NCT04715269 is registered in ClinicalTrials.gov with Sohaib Ashraf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Alprazolam on Heart Rate and Acute Inflammatory Marker in Acute Coronary Syndrome Patients
- Lead sponsor
- Sohaib Ashraf
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 25, 2020
- Completion date
- February 20, 2022
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.